Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,170,559
-$728,221 QoQ
Shares Held
173,196
-0.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#665
of 2,821 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAYMARK WEALTH PARTNERS, LLC holds $218,773,359 across 12 Drug Manufacturers - General names. PFE ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
266,410 | $67,660,147 | |
| 2 | AMGN |
Amgen Inc
|
150,438 | $54,476,608 | |
| 3 | ABBV |
AbbVie Inc.
|
130,459 | $32,828,702 | |
| 4 | LLY |
ELI LILLY & Co
|
25,552 | $30,647,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
81,443 | $10,465,425 | |
| 6 | NVS |
Novartis AG
|
43,852 | $6,872,485 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
85,038 | $4,899,889 | |
| 8 | PFE |
Pfizer Inc
This page
|
173,196 | $4,170,559 |
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,170,559 | 173,196 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,898,780 | 174,458 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,368,480 | 175,441 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,476,453 | 175,685 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,531,907 | 228,214 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,176,194 | 243,733 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,140,018 | 269,130 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $8,462,663 | 292,421 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $8,247,832 | 294,776 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,713,362 | 277,959 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $7,828,432 | 271,915 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $8,671,964 | 261,440 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $8,413,878 | 229,386 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,581,620 | 63,275 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,046,423 | 39,938 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||